Archive

RHÖN-KLINIKUM AG | 01/27/2014

Clearance of Fresenius Transaction by Merger Control Authorities Appears Imminent

Hospitals in Cuxhaven, Waltershausen-Friedrichroda and Boizenburg Initially to Remain with RHÖN for Merger Control Reasons The hospitals in Cuxhaven, Waltershausen-Friedrichroda and Boizenburg have been removed from…

RHÖN-KLINIKUM AG | 12/23/2013

Merger control clearance of the transaction with Fresenius Helios expected for early 2014 – Partial distribution of the sales proceeds still planned for 2014 – Appointments to two positions on the supervisory board

On the basis of the information currently available from the competition authorities and the transaction partner Fresenius Helios it is becoming apparent that the German competition authority (Bundeskartellamt) will…

RHÖN-KLINIKUM AG | 11/07/2013

Interim Report on Q3: Continued Growth in Patient Numbers and Revenue – Sale of 43 Hospitals Proceeding on Schedule

Patient numbers increase 5.6% year-on-year on a nine-month BasisRevenue grows 6.3% to €2.26 billionEBITDA goes up by 3.3%Transaction on schedule – transfer of companies expected in the planned volume by the end of the…

RHÖN-KLINIKUM AG | 09/13/2013

RHÖN-KLINIKUM AG goes on the offensive with fundamental realignment of its corporate structure and strategy

Future focus on advanced medicine Sale of 43 hospitals and affiliated companies to Fresenius Helios Build-up of mutual network with high-quality offering for patients M-Dax listed hospital operator RHÖN-KLINIKUM AG…

RHÖN-KLINIKUM AG | 08/08/2013

RHÖN-KLINIKUM AG witnesses pleasing Q2 growth

RHÖN-KLINIKUM AG reports growth of 7.1% growth in patient numbers versus H1 of previous yearRevenues increase by 8.4% to more than EUR 1.5 billionNet consolidated profit for H1 of 2013 amounts to EUR 50.8 million (same…

RHÖN-KLINIKUM AG | 07/30/2013

RHÖN-KLINIKUM AG: Intended increase of Asklepios’ shareholding in RHÖN-KLINIKUM AG to 10.1% of all shares prohibited by Federal Cartel Office

By resolution dated 12 March 2013, the German Federal Cartel Office (Bundeskartellamt) had approved the increase of Asklepios Verwaltungsgesellschaft mbH’s (“Asklepios“) shareholding in RHÖN-KLINIKUM AG to 10.1% subject…

RHÖN-KLINIKUM AG | 07/16/2013

Announcement pursuant Sections 246 para. 4 sentence 1, 249 para. 1 sentence 1 of the German Stock Corporation Act (AktG)

According to Sections 246 para. 4 sentence 1, 249 para. 1 sentence 1 AktG we hereby announce that a shareholder has filed legal action for annulment (Section 246 AktG) and ascertainment of voidance (Section 249 AktG)…

RHÖN-KLINIKUM AG | 06/13/2013

Annual General Meeting of RHÖN-KLINIKUM AG on 12 June 2013 in Frankfurt am Main

Results for financial year 2012 Rise in patient treatments by over 12 per cent further demonstrates trust in high medical qualityGain of 9 per cent in revenues amid difficult regulatory environmentPerformance figures…

RHÖN-KLINIKUM AG | 06/12/2013

Annual General Meeting of RHÖN-KLINIKUM AG resolves to eliminate 90% clause

The Annual General Meeting of RHÖN-KLINIKUM AG resolved today to delete the requirement of a majority of more than 90% of the represented registered share capital provided for in Section 17 (4), 1st sub-paragraph of the…

RHÖN-KLINIKUM AG | 04/25/2013

Accounts press conference in Frankfurt am Main on 25 April 2013

Annual results 2012 Renewed increase in patients treated of 12.2 % is evidence of confidence in the quality of care and medical capability9.0 % revenue growth in a challenging regulatory environmentGrowth driven by the…